Budget impact and transferability of cost-effectiveness of DPYD testing in metastatic breast cancer in 3 health systems - supplementary material

  • Rositsa Koleva-Kolarova (Creator)
  • Heleen Vellekoop (Creator)
  • Simone Huygens (Creator)
  • Matthijs Versteegh (Creator)
  • Maureen van Molken (Contributor)
  • László Szilberhorn (Contributor)
  • Tamás Zelei (Contributor)
  • Balázs Nagy (Creator)
  • Sarah Wordsworth (Creator)
  • Apostolos Tsiachristas (University of Oxford, Oxford University Hospitals NHS Foundation Trust) (Creator)

Dataset

Description

Appendix Table 1. General (UK) model input parameters
Date made available2023
PublisherFuture Science Group

Cite this